All Stories

  1. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease
  2. Mycobiota in gastrointestinal diseases
  3. Les levures opportunistes émergentes
  4. Genetic Diversity Among Candida albicans Isolates Associated with Vertical Transmission in Preterm Triplets
  5. Nouveaux marqueurs pour le diagnostic de la maladie fongique invasive
  6. Factors predicting prolonged empirical antifungal treatment in critically ill patients
  7. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation
  8. Detection of (1,3)-β-D-glucans in situ in a Candida albicans brain granuloma
  9. Implication de la flore fongique intestinale dans le développement de la maladie de Crohn
  10. An immunological link betweenCandida albicanscolonization and Crohn’s disease
  11. Aspergillus endocarditis in the era of new antifungals: Major role for antigen detection
  12. The CARD8 p.C10X mutation associates with a low anti-glycans antibody response in patients with Crohn’s disease
  13. Characterization of the recognition of Candida species by mannose-binding lectin using surface plasmon resonance
  14. Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals
  15. Antifungal Activity of 10 Guadeloupean Plants
  16. Secukinumab failure in Crohn's disease: the yeast connection?
  17. Strategy for Overcoming Serum Interferences in Detection of Serum (1,3)-β-d-Glucans: Fig 1
  18. Mannose-Binding Lectin Levels and Variation During Invasive Candidiasis
  19. Biotin sulfone tagged oligomannosides as immunogens for eliciting antibodies against specific mannan epitopes
  20. Variants of NOD1 and NOD2 genes display opposite associations with familial risk of crohnʼs disease and anti-saccharomyces cerevisiae antibody levels
  21. Evaluation of a Recombinant Antigen-Based Enzyme Immunoassay for the Diagnosis of Noninvasive Aspergillosis
  22. Synthetic biotinylated tetra β(1→5) galactofuranoside for in vitro aspergillosis diagnosis
  23. Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model
  24. Molecular Identification of Closely Related Candida Species Using Two Ribosomal Intergenic Spacer Fingerprinting Methods
  25. Changes Related to Age in Natural and Acquired Systemic Self-IgG Responses in Malaria
  26. Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohnʼs disease
  27. Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans
  28. Candida albicans Colonization and ASCA in Familial Crohn's Disease
  29. Glycannes pariétaux de levures et anticorps spécifiques
  30. Yeasts: Neglected Pathogens
  31. Biotin Sulfone as a New Tool for Synthetic Oligosaccharide Immobilization: Application to Multiple Analysis Profiling and Surface Plasmonic Analysis of Anti- Candida albicans Antibody Reactivity against α and β (1→2) Oligomannosides †
  32. Colonization of Mice by Candida albicans Is Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin‐3
  33. Detection of Antisynthetic Mannoside Antibodies (AΣMA) Reveals Heterogeneity in the ASCA Response of Crohn's Disease Patients and Contributes to Differential Diagnosis, Stratification, and Prediction
  34. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiaeantibodies in Crohn's disease patients, their relatives or associated clinical factors
  35. Evaluation of VITEK 2 colorimetric cards versus fluorimetric cards for identification of yeasts
  36. Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study
  37. Is Candida kefyr an Emerging Pathogen in Patients with Oncohematological Diseases?
  38. Candida albicans Is an Immunogen for Anti–Saccharomyces cerevisiae Antibody Markers of Crohn’s Disease
  39. Zygomycose pulmonaire chez un patient traité pour une aspergillose invasive possible
  40. Synthetic yeast oligomannosides as biological probes: α-d-Manp (1→3) α-d-Manp (1→2) α-d-Manp and α-d-Manp (1→3) α-d-Manp (1→2) α-d-Manp (1→2) α-d-Manp as Crohn's disease markers
  41. Relevance of serologic studies in inflammatory bowel disease
  42. Greffe rénale et artérite du greffon à Candida albicans
  43. Panel of serologic antibodies in patients with indeterminate colitis
  44. Serological markers in inflammatory bowel diseases
  45. The value of serologic markers in indeterminate colitis: A prospective follow-up study
  46. Evaluation of Serologic Disease Markers in a Population-Based Cohort of Patients with Ulcerative Colitis and Crohn's Disease
  47. ASCA (anti-saccharomyces cerevisiae antibodies) in healthy relatives of sporadic and familial Crohn's disease patients
  48. ASCA (anti-saccharomyces cerevisiae antibodies) in healthy relatives of sporadic and familial Crohn's disease patients
  49. Anti-saccharomyces cerevisiae mannan (ASCA) antibodies in inflamatory bowel disease (IBD)
  50. Surgery is associated with fluctuations in ASCA levels suggesting antigenic stimulation
  51. Is ASCA (anti-saccharomyces cerevisiae antibodies) related to the major histocompatibility complex (HLA)?
  52. Are anti-saccharomyces cerevisiae antibodies (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (PANCA) useful in indeterminate colitis? A prospective follow-up study
  53. Nature of Candida albicans -derived carbohydrate antigen recognized by a monoclonal antibody in patient sera and distribution over Candida species
  54. Anti-Saccharomyces cerevisiae Mannan Antibodies in Familial Crohn's Disease
  55. Anti-Saccharomyces cerevisiae mannan antibodies in familial crohn's disease
  56. Confirmation of the importance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease
  57. Stratification of Crohn's disease by anti Saccharomyces cerevisiae mannan antibodies (ASCA) and antineutrophil cytoplasmic antibodies (ANCA)
  58. Specific Diagnostic Antigens ofEchinococcus Granulosusdetected by western blot